104 related articles for article (PubMed ID: 8019610)
1. [Treatment of cystic mastopathy with puncture and administration of an LHRH analogue].
Colin C
Contracept Fertil Sex; 1994 Mar; 22(3):183-6. PubMed ID: 8019610
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content.
Boccardo F; Valenti G; Zanardi S; Cerruti G; Fassio T; Bruzzi P; De Franchis V; Barreca A; Del Monte P; Minuto F
Cancer Res; 1988 Oct; 48(20):5860-3. PubMed ID: 2971432
[TBL] [Abstract][Full Text] [Related]
3. Influence of hormonal status of patients with cystic disease on the composition of cyst fluid and breast cancer risk.
Budai B; Számel I; Sulyok Z; Németh M; Bak M; Kralovánszky J; Ottó S; Besznyák I; Purohit A; Parish DC; Reed MJ
Anticancer Res; 2000; 20(5C):3879-86. PubMed ID: 11268470
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.
Sverrisdóttir A; Fornander T; Jacobsson H; von Schoultz E; Rutqvist LE
J Clin Oncol; 2004 Sep; 22(18):3694-9. PubMed ID: 15365065
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
Bernhard J; Zahrieh D; Castiglione-Gertsch M; Hürny C; Gelber RD; Forbes JF; Murray E; Collins J; Aebi S; Thürlimann B; Price KN; Goldhirsch A; Coates AS;
J Clin Oncol; 2007 Jan; 25(3):263-70. PubMed ID: 17159194
[TBL] [Abstract][Full Text] [Related]
6. Biochemical analysis of breast cyst fluid as a possible predictor of breast carcinoma development.
Simíøcková M; Pecen L; Eben K; Nekulová M; Vermousek I; Stratil P; Rejthar A; Cernoch M; Lang B; Sakalová J
Neoplasma; 1994; 41(5):245-52. PubMed ID: 7854493
[TBL] [Abstract][Full Text] [Related]
7. Oestradiol and epidermal growth factor in breast cyst fluid.
Lai LC; Dunkley SA; Reed MJ; Ghilchik MW; James VH
Anticancer Res; 1989; 9(6):1853-6. PubMed ID: 2627131
[TBL] [Abstract][Full Text] [Related]
8. [Clinical effects of a 3-month formulation LH-RH agonist (Zoladex LA 10.8 mg depot) in patients with prostate cancer].
Kotake T; Akaza H; Usami M; Naito S; Kanetake H; Taguchi T; Tsukagoshi S; Koiso K
Hinyokika Kiyo; 2001 May; 47(5):349-61. PubMed ID: 11433759
[TBL] [Abstract][Full Text] [Related]
9. Lipids status in human breast cyst fluids.
Mannello F; Bocchiotti GD; Morano FP; Fratepietro LM; Gazzanelli G
Cancer Lett; 1996 Jan; 98(2):137-43. PubMed ID: 8556700
[TBL] [Abstract][Full Text] [Related]
10. Association of breast cysts and breast cancer.
Devitt JE
Can J Surg; 1988 Sep; 31(5):356-8. PubMed ID: 3416250
[TBL] [Abstract][Full Text] [Related]
11. European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia.
Mansel RE; Goyal A; Preece P; Leinster S; Maddox PR; Gateley C; Kubista E; von Fournier D
Am J Obstet Gynecol; 2004 Dec; 191(6):1942-9. PubMed ID: 15592276
[TBL] [Abstract][Full Text] [Related]
12. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
13. Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
Davidson NE; O'Neill AM; Vukov AM; Osborne CK; Martino S; White DR; Abeloff MD
J Clin Oncol; 2005 Sep; 23(25):5973-82. PubMed ID: 16087950
[TBL] [Abstract][Full Text] [Related]
14. Electrolytes and trace elements in human breast cyst fluid.
Sişman AR; Sis B; Canda T; Onvural B
Biol Trace Elem Res; 2009 Apr; 128(1):18-30. PubMed ID: 18972071
[TBL] [Abstract][Full Text] [Related]
15. Use of goserelin in the treatment of breast cancer.
Rody A; Loibl S; von Minckwitz G; Kaufmann M
Expert Rev Anticancer Ther; 2005 Aug; 5(4):591-604. PubMed ID: 16111461
[TBL] [Abstract][Full Text] [Related]
16. CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93).
von Minckwitz G; Graf E; Geberth M; Eiermann W; Jonat W; Conrad B; Brunnert K; Gerber B; Vescia S; Wollert J; Kaufmann M
Eur J Cancer; 2006 Aug; 42(12):1780-8. PubMed ID: 16765589
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma.
Recchia F; Saggio G; Amiconi G; Di Blasio A; Cesta A; Candeloro G; Rea S
Cancer; 2006 Feb; 106(3):514-23. PubMed ID: 16388519
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment of breast cysts].
Vetshev PS; Kuznetsov NS; Bel'tsevich DG; Ozerov SK
Khirurgiia (Mosk); 1998; (7):7-11. PubMed ID: 9791961
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study.
Baum M; Hackshaw A; Houghton J; Rutqvist ; Fornander T; Nordenskjold B; Nicolucci A; Sainsbury R;
Eur J Cancer; 2006 May; 42(7):895-904. PubMed ID: 16545560
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of hepatic hydatid cysts by percutaneous aspiration and hypertonic saline injection: results of a cooperative work].
Peláez V; Kugler C; del Carpio M; Correa D; López E; Larrieu E; Guangiroli M; Molina J
Bol Chil Parasitol; 1999; 54(3-4):63-9. PubMed ID: 10883492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
